DailyIQ
DailyIQ
Last updatedjust now

CLBT·Cellebrite DI Ltd.

$11.54
+0.65 (+5.97%)
After Hours
High
$11.85
Open
$11.02
Market Cap
2.90B
52W High
$19.50
Low
$10.88
P. Close
$11.54
P/E
49.32
52W Low
$9.58
Fwd P/E
17.23
DailyIQ Est.
$16.25
Inst. Own.
12.8%
Short Interest
2.88%
Days to Cover
3.8
Technical Score (1D)
6
BEARISH
News Sentiment
63
BULLISH
On Nov 12, Cellebrite DI Ltd reported third‑quarter 2026 results that included a 20% year‑over‑year increase in annual recurring revenue to $528.5 million and an 18% rise in total revenue to $149 million, driven by stronger U.S. federal demand and international expansion. The company also highlighted a successful launch of a new AI product and progress on its U.S. redomicile strategy, indicating continued operational momentum. Adjusted EBITDA grew 42% to $53.6 million and free cash flow remained robust at $52 million, underscoring the firm’s profitability. Despite these gains, the company lowered its FY2026 sales guidance to $553 million‑$558 million, a modest tightening that reflected competitive headwinds. The guidance cut was noted as a small negative signal, while the company maintained its operating margin targets and reiterated its focus on expanding its digital forensics platform. Overall, the quarter delivered a positive performance with record recurring revenue growth, but the guidance adjustment tempered the outlook.
LOW TARGET
$13 +8.3%
2 analysts
MEAN TARGET
$15 +33.1%
5 analysts
HIGH TARGET
$20 +73.3%
10 analysts
PRICE RANGE
$12.50 - $20.00
SB / B / H / S / SS
4/10/1/1/1
DAILYIQ EST.
$16.25 (+40.8%)
Bought (1Y)
0 shares
$0
Sold (1Y)
197,497 shares
$2.8M
GEE DAVID NICHOLASChief Marketing Officer
Sell234 shares2026-11-12
Jewell MarcusGlobal Chief Revenue Officer
Sell393 shares2026-11-12
Barter DavidChief Financial Officer
Sell12,134 shares2026-10-16
Ramji ShivenChief Executive Officer
Award/Grant38,505 shares2026-09-24
Domnitz Yonatan-
Award/Grant15,190 shares2026-09-17
87/ 100
Strong bullish
Overall: Bullish
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Gross Margin
84.2%
Net Margin
16.5%
Revenue CAGR
18.5%
Current Ratio
1.56x
Return on Equity
16.2%

EPS

EstBeatMiss
$0.12$0.14$0.15$0.17$0.19Q3'25Q3'26Q4'26
QtrEstActual+/−
Q4'26$0.18 - -
Q3'26$0.16$0.17+5.5%
Q3'25$0.13$0.14+8.5%

Revenue

EstBeatMiss
$122M$131M$140M$149M$158MQ3'25Q3'26Q4'26
QtrEstActual+/−
Q4'26$154M - -
Q3'26$149M$149M+0.1%
Q3'25 - $126M -

Market Data

CLBT Stock Snapshot

BEARISH6/100
$11.54+$0.00 (0.0%)
Market cap
2.90B
P/E ratio
49.3
Day range
$10.88 – $11.85
News sentiment
63/100 · Bullish
Analyst target
$15.36 (+33.1%)
Consensus
Buy · 17 analysts
52-week range+20.5% off low · -40.8% from high
$9.58$19.50
Price $11.54 DailyIQ Est. $16.25

The chart on CLBT has not stabilised: price is in the lower half of its 52-week range and the trend is still down. Company-specific news dominates here; sector-level flows matter less than for larger names.

Behaviour On Record

What CLBT's own history says about today's numbers

Realized volatility (21d)
64.9% 82nd pct
Below its peak
-57.4%
vs 200-day average
-16.5%
Up days (1y)
45%

Cellebrite DI Ltd. is currently running 64.9% annualised volatility over the last 21 sessions. Measured against CLBT's own 6 years of daily returns rather than a market-wide average, that is the 82nd percentile — elevated for this stock, against a typical reading of 45.0%.

CLBT is trading -57.4% below its running peak. Across 6 full years on file, its median worst-drawdown-in-a-year was -41.4%, and the deepest was -51.7% in 2022. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began, and where past declines also continued.

Price sits -16.5% from its 200-day moving average. Against every other day in its history, that gap ranks at the 28th percentile — a narrower gap than it typically runs. Over the past year CLBT closed higher on 45% of sessions, and it is currently 1 session into a rising streak.

On November specifically: over 7 years of records, CLBT finished the month higher 4 of 7 times, with a median return of +1.4% and an average of -0.4%. Its strongest month historically has been October at +7.1% on average, its weakest September at -5.5%.

Overnight risk is measurable too: CLBT has opened more than 2% away from the prior close in 234 of 1,510 sessions (15.5% of the time), with the largest gaps running +13.0% and -8.4%.

All figures computed from 1,511 daily closes between 2020-11-06 and 2026-11-13, split-adjusted, recomputed daily. Percentiles are against CLBT's own 6-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of CLBT's sector?

Cellebrite DI Ltd. sits in the Software sector, currently ranked 11th of 12 GICS sectors by relative-strength rotation score (improving). Within its narrower Software industry group, CLBT ranks 14th of 15 tracked industries, improving.

Sector rank
#11 of 12
Sector state
Improving
Sector rotation score
0
Industry rank
#14 of 15

Options Market

What is the options market pricing for CLBT?

CallsPuts

For Cellebrite DI Ltd.'s nearest expiry (2026-11-20, 5 days out), open interest is call-heavy, a bullish tilt (put/call ratio of 0.23), with at-the-money implied volatility around 68.0%. The options market is pricing roughly a ±9.6% move by that expiry — a range of about $10.49–$12.73.

Put/call ratio (2026-11-20)
0.23
ATM implied volatility
68.0%
Total open interest
1,801
Expected move by 2026-11-20
±9.6% ($10.49–$12.73)

Analyst Consensus Estimates

What do analysts expect CLBT to earn?

Analysts expect Cellebrite DI Ltd. to earn $0.55 per share in the fiscal year ending Dec 2026 and $0.59 in the fiscal year ending Dec 2028, from 2 estimates. These are analyst forecasts, not company guidance, and later years rest on fewer analysts.

Quarter endingEPS estimateEPS rangeEPS analystsRevenue estimateRevenue analysts
Sep 2026$0.16$0.14 to $0.178$146M8
Dec 2026$0.18$0.16 to $0.198$151M8
Mar 2027$0.11$0.11 to $0.112~$138M-
Jun 2027$0.12$0.11 to $0.122~$151M-
Sep 2027$0.14$0.12 to $0.152~$176M-
Fiscal year endingEPS estimateEPS rangeEPS analystsRevenue estimateRevenue analysts
Dec 2026$0.55$0.42 to $0.598$557M8
Dec 2027$0.65$0.54 to $0.738$641M8
Dec 2028$0.59$0.53 to $0.652~$741M-

Revenue marked ~ is our calculation from the EPS estimate, not analyst consensus.

Analyst Rating Changes

Are analysts turning bullish or bearish on CLBT?

DA Davidson most recently reiterated its rating on Cellebrite DI Ltd. to Buy on Sep 15, 2026 with a price target of $15. Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action
DA Davidson: Buy
90-day upgrades
0
90-day downgrades
0
Net rating momentum
0
DateFirmActionRatingPrice target
Sep 15, 2026DA DavidsonMaintainedBuy$15
Aug 14, 2026Lake StreetMaintainedBuy$21 → $15
Aug 14, 2026JP MorganMaintainedOverweight$20 → $16
Aug 14, 2026DA DavidsonMaintainedBuy$22 → $15
Aug 14, 2026NeedhamMaintainedBuy$15 → $13
Aug 6, 2026DA DavidsonMaintainedBuy$20 → $22
May 27, 2026DA DavidsonInitiatedBuy$20
May 15, 2026NeedhamMaintainedBuy$18 → $15
Feb 12, 2026NeedhamMaintainedBuy$24 → $18
Nov 13, 2025JP MorganMaintainedOverweight$23 → $24
Nov 13, 2025Lake StreetMaintainedBuy$22 → $23
Nov 13, 2025B of A SecuritiesMaintainedBuy$24 → $25

Corporate Stakes

Which companies own a stake in CLBT?

0.52%held by AXON

Axon Enterprise, Inc. reports a stake in Cellebrite DI Ltd. on SEC Form 13F: 1.3M shares, about 0.52% of the company, worth $14.8M at the end of Q3 2026. At today's price that stake is worth $15.1M, about 0.06% of AXON's own market value.

Holder
AXON
Shares held
1.3M
Stake
0.52%
Value
$14.8M
HolderLast quarterShares% of CLBTValue at filingValue nowChange
Axon Enterprise, Inc. AXONUnchanged1.3M0.52%$14.8M$15.1M+2.5%

Form 13F lists US-listed shares held at quarter-end and is filed up to 45 days later. Stakes in private companies are not on it. Value now and Change put those same shares, adjusted for any stock split, at today's price against their reported quarter-end value, so they do not reflect buying or selling since.

News & sentiment

What is the news saying about CLBT?

CLBT rose 1.3% over the month to Nov 13. News tone held between 39 and 80 from Oct 20 to Nov 11, then jumped to 63 on Nov 12.

Daily close and news tone, Oct 13 to Nov 13
$11$12$13Oct 13Oct 14Oct 15Oct 16Oct 19Oct 20: tone 48Oct 21: tone 80Oct 22Oct 23Oct 26Oct 27Oct 28Oct 29Oct 30: tone 43Nov 2Nov 3: tone 50Nov 4Nov 5: tone 47Nov 6: tone 50Nov 9: tone 50Nov 10: tone 50Nov 11: tone 39Nov 12: tone 63Nov 13: tone 60Oct 13News toneNov 13123
  1. Nov 3 +5.4%
  2. Nov 12 -14.3%same day: Cellebrite Reports Third-Quarter 2026 Results
  3. Nov 13 +5.9%same day: Cellebrite (CLBT) Q3 2026 Earnings Call Transcript
Latest stories naming Cellebrite DI

Technical analysis

How strong is CLBT's momentum right now?

On the daily chart CLBT ranks at the 6th percentile for momentum against 1,062 stocks and ETFs, a bearish reading.

Momentum rank by timeframe0 = weakest, 100 = strongest
See what drives the rankThe inputs behind each timeframe's momentum rank, plus RSI, stochastics, Bollinger Bands and moving averages. Free with an account.

Institutional ownership

Are big funds buying or selling CLBT?

24 of the 53 tracked managers added to CLBT in their latest 13F and 23 trimmed. Together they own 12.3% of the company, worth $345.6M. BlackRock and Citigroup alone hold 3.0%.

24adding23trimming6unchanged
Largest holders by stake, latest 13FBar = share of CLBT
  1. $49.6M positionNew position last quarter
  2. $36.5M positionNew position last quarter
  3. $27.1M positionNew position last quarter
  4. $23.9M positionTrimmed 78.7% last quarter
  5. $23.8M positionNew position last quarter
  6. $23.3M positionAdded 18.6% last quarter
  7. $23.1M positionTrimmed 0.3% last quarter
  8. $21.6M positionNew position last quarter
  9. $18.5M positionAdded 1.6M shares last quarter
  10. $16.5M positionAdded 192.3% last quarter
Full holdings history

Discover more

How has CLBT done against its peers?

Over the six months to Nov 13, CLBT returned −7.6%. Of the 15 related stocks and ETFs, 10 did better, led by SNOW at +90.6%.

Change since May 13, through Nov 13
−50%0%+50%+100%+150%May 13JulAugSepOctNov 13SNOW +90.6%CLBT −7.6%ORCL −34.3%